SEC Form 4 · Insider disclosures

Recent Insider Selling

Recent sales grouped by company, with disclosed plans and holdings context. A sale alone does not establish a bearish view.

Purchase rows312
Sale rows1,613
Purchase value (USD)US$469.72M
Sale value (USD)US$1.44B

Last 10 days of filings·Updated Oct 23, 3:53 AM ET

Recent company disclosures

328 companies · 1,613 rows
SNEX

StoneX Group Inc.

Sale total ≈ US$5.87M

2 transaction rows · 2 filings

Smith Philip Andrew

Sale
CEO / Director disclosed sale of 45,000 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 738K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$2.68M

Maurer Mark Lowry

Sale
Reporting owner disclosed sale of 52,953 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 220K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$3.2M
QVCG

QVC Group, Inc.

Sale total ≈ US$16.78M

2 transaction rows · 2 filings

OAKTREE CAPITAL MANAGEMENT LP / Oaktree Capital Holdings, LLC

Sale
10% owner disclosed sale of 5,224 shares

Filing did not check the 10b5-1 plan indicator

Approximately 7.21M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$80.97K

Silver Point Capital, L.P. / MULE EDWARD A / O'Shea Robert J

Sale
10% owner disclosed sale of 1,352,000 shares

Filing did not check the 10b5-1 plan indicator

Approximately 4.95M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$16.7M
BUKS

BUTLER NATIONAL CORP

Sale total ≈ US$236.47K

3 transaction rows · 1 filings

Zeff Capital, LP

Sale
10% owner disclosed sale of 10,303 shares

Filing did not check the 10b5-1 plan indicator

Approximately 7.33M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$48.22K

Zeff Capital, LP

Sale
10% owner disclosed sale of 5,000 shares

Filing did not check the 10b5-1 plan indicator

Approximately 7.33M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$24K
Show 1 more transaction rows

Zeff Capital, LP

Sale
10% owner disclosed sale of 34,800 shares

Filing did not check the 10b5-1 plan indicator

Approximately 7.29M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$164.26K
LIF

Life360, Inc.

Sale total ≈ US$343.29K

1 transaction rows · 1 filings

Prober Charles J.

Sale
Director disclosed sale of 7,930 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 110K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$343.29K
ONC

BeOne Medicines Ltd.

Sale total ≈ US$10.89M

5 transaction rows · 1 filings

Wang Xiaodong

Sale
Director disclosed sale of 7,167 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 23.9K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$2.51M

Wang Xiaodong

Sale
Director disclosed sale of 10,361 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 13.5K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$3.63M
Show 3 more transaction rows

Wang Xiaodong

Sale
Director disclosed sale of 5,681 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 7.82K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$2M

Wang Xiaodong

Sale
Director disclosed sale of 6,558 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.26K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$2.31M

Wang Xiaodong

Sale
Director disclosed sale of 1,260 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 0 shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$445.08K
APLD

Applied Digital Corp.

Sale total ≈ US$682.5K

1 transaction rows · 1 filings

Nottenburg Richard N

Sale
Director disclosed sale of 31,250 shares

Filing did not check the 10b5-1 plan indicator

Sale represented approximately 23.42% of prior direct holdings; approximately 102K shares remain

Calculated transaction value approximately US$682.5K
NRIX

Nurix Therapeutics, Inc.

Sale total ≈ US$564.83K

2 transaction rows · 2 filings

Hansen Gwenn

Sale
Officer disclosed sale of 1,452 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 117K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$36.3K

GREGORY JULIA P

Sale
Director disclosed sale of 22,583 shares

Filing did not check the 10b5-1 plan indicator

Approximately 10.8K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$528.53K
KNTK

Kinetik Holdings Inc.

Sale total ≈ US$109.54M

1 transaction rows · 1 filings

ISQ Global Fund II GP LLC / I Squared Capital, LLC / ISQ Holdings, LLC / Wahba Sadek / Bhandari Gautam

Sale
10% owner disclosed sale of 2,000,000 shares

Filing did not check the 10b5-1 plan indicator

Approximately 1 shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$109.54M
RSKD

RISKIFIED LTD.

Sale total ≈ US$543.13K

1 transaction rows · 1 filings

Kumaraswami Ravi

Sale
Officer disclosed sale of 65,000 shares

Disclosed 10b5-1 trading plan

Sale represented approximately 4.36% of prior direct holdings; approximately 1.42M shares remain

Calculated transaction value approximately US$543.13K
ARQQ

Arqit Quantum Inc.

Sale total ≈ US$42.21K

1 transaction rows · 1 filings

Leaver Andrew

Sale
CEO disclosed sale of 2,573 shares

Filing did not check the 10b5-1 plan indicator

Sale represented approximately 4.55% of prior direct holdings; approximately 54K shares remain

Calculated transaction value approximately US$42.21K
HIMS

Hims & Hers Health, Inc.

Sale total ≈ US$100.58K

1 transaction rows · 1 filings

Boughton Soleil

Sale
Officer disclosed sale of 3,461 shares

Disclosed 10b5-1 trading plan

Sale represented approximately 1.15% of prior direct holdings; approximately 297K shares remain

Calculated transaction value approximately US$100.58K
LWAY

Lifeway Foods, Inc.

Sale total ≈ US$679.2K

1 transaction rows · 1 filings

SMOLYANSKY EDWARD

Sale
10% owner disclosed sale of 30,000 shares

Filing did not check the 10b5-1 plan indicator

Sale represented approximately 3.35% of prior indirect holdings; approximately 865K shares remain

Calculated transaction value approximately US$679.2K
Sources, coverage & updates
SEC filing dates: 2026-10-14 — 2026-10-23 (America/New_York)

Current-day data is provisional; historical dates are reconciled to official daily indexes.

Last successful sync: Oct 23, 3:53 AM ET

Historical dates reconciled; current day provisional

Discovered filings 2,284 · Parsed 2,284 · Pending 0

Table I non-derivative P/S only. Values use reported price × shares; 9 unavailable, unverified or non-USD amounts are excluded. 743 filings · 691 distinct reporting owners, not necessarily independent decision-makers.

Company grouping is a reading aid, not a merger of transactions or uncertain ownership ratios. Value sorting uses each company’s usable total; expand to see every matching row.

Reading these disclosures

Form 4 disclosures are not real-time trade alerts. An unchecked 10b5-1 indicator does not establish discretionary timing. Direct and indirect holdings remain separate; unresolved amendments stay under review.

Filed prices are not all independently market-verified. Source: SEC EDGAR; the update target is every 15 minutes. Actual freshness is shown by the last successful synchronization.

SEC transaction codes ↗